Home

The Korea Herald

Latest news

Most Popular

  1. 1

    Contentious grain bill put directly to plenary meeting for vote

    Contentious grain bill put directly to plenary meeting for vote
  2. 2

    Yoon's approval rating plunges to all-time low

    Yoon's approval rating plunges to all-time low
  3. 3

    Will tug-of-war between doctors, government end soon?

    Will tug-of-war between doctors, government end soon?
  4. 4

    Climate impacts set to cut 2050 global GDP by nearly a fifth

    Climate impacts set to cut 2050 global GDP by nearly a fifth
  5. 5

    Trilateral talks acknowledge ‘serious’ slumps of won, yen

    Trilateral talks acknowledge ‘serious’ slumps of won, yen
  1. 6

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs

    [KH Explains] Hyundai's full hybrid edge to pay off amid slow transition to pure EVs
  2. 7

    North Korea removes streetlights along cross-border roads with South

    North Korea removes streetlights along cross-border roads with South
  3. 8

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official

    Russia's denial of entry of S. Korean national unrelated to bilateral ties: Seoul official
  4. 9

    Farming households dip below 1m for first time in 2023

    Farming households dip below 1m for first time in 2023
  5. 10

    S. Korea votes in favor of Palestinian bid for UN membership

    S. Korea votes in favor of Palestinian bid for UN membership
지나쌤

Samsung BioLogics obtains 6 production permits

By 최희석

Published : Sept. 7, 2016 - 11:11

    • Link copied

[THE INVESTOR] Samsung BioLogics announced on Sept. 7 that it received six manufacturing licenses from the European Medicines Agency and the US Food and Drug Administration.

Samsung BioLogics is the world’s third largest biologics contract manufacturer by capacity.

With the latest licenses, Samsung BioLogics now has seven production licenses. 



A contract manufacturer is required to obtain production licenses before operations can begin regardless of whether the product has been approved by the authorities.

By Choi He-suk (cheesuk@heraldcorp.com)

More from Headlines